article thumbnail

IN FOCUS: Syngene International

Pharmaceutical Technology

The company has been ranked in the Business Expansion and Research and Development categories in the Pharmaceutical Technology Excellence Rankings. Initially centered on Librela®, this agreement paves the way for developing and manufacturing other molecules in the coming years. until 2026. until 2026.

article thumbnail

Overcoming inefficiencies to improve access to cell and gene therapy 

Drug Discovery World

While there is no silver bullet for increasing the availability of CGTs, improving manufacturing processes that enable their development at scale can help reduce the cost of these treatments and get them to those who need them most. But now, the increased efficiency is likely making drug development cheaper.